Advertising Disclaimer
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stephensen, C. B.
Right arrow Articles by Alvarez, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephensen, C. B.
Right arrow Articles by Alvarez, J. O.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 101 No. 5 May 1998, p. e3

ELECTRONIC ARTICLE:
Adverse Effects of High-dose Vitamin A Supplements in Children Hospitalized With Pneumonia

Received Sep 8, 1997; accepted Dec 12, 1997.

Charles B. Stephensen*, Luis Miguel FranchiDagger , Herminio HernandezDagger , Miguel Campos§, Robert H. Gilmanpar , , #, and Jose O. Alvarez*

From the * Department of International Health, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Departments of Dagger  Pediatrics, § Mathematics, and par  Pathology, Universidad Peruana Cayetano Heredia, Lima, Peru;  Department of International Health, School of Public Health, Johns Hopkins University, Baltimore, Maryland; and # A.B. PRISMA, Lima, Peru.

Objective.  To test the hypothesis that high-dose vitamin A supplements will enhance recovery of children hospitalized for the treatment of community-acquired pneumonia.

Design.  We conducted a randomized, double-blind, placebo-controlled clinical trial of high-dose vitamin A supplements among children 3 months to 10 years of age (N = 95) admitted to hospital with community-acquired pneumonia in Lima, Peru. Children <= 1 year of age received 100 000 IU of water-miscible vitamin A on admission to the hospital and an additional 50 000 IU the next day. Children >1 year of age received 200 000 IU on admission and 100 000 IU the next day.

Results.  Children receiving vitamin A (n = 48) had lower blood oxygen saturation (the mean difference on day 3 in hospital was 1.1%), higher prevalence rates of retractions (37% in the vitamin A group vs 15% in the placebo group on day 3), auscultatory evidence of consolidation (28% in the vitamin A group vs 17% in the placebo group on day 3), and were more likely to require supplemental oxygen (21% in the vitamin A group vs 8% in the placebo group on day 3) than children in the placebo group (n = 47). Adjustment for baseline severity of disease and nutritional status did not alter the association of vitamin A with increased clinical severity, although the difference in blood oxygen saturation was no longer statistically significant. No differences were seen in duration of hospitalization or in chest x-ray changes 14 days after admission. No deaths occurred, and toxicity of vitamin A was not seen.

Conclusions.  This study indicates that high-dose vitamin A supplements cause modest adverse effects in children recovering from pneumonia and should not be used therapeutically in such patients unless there is clinical evidence of vitamin A deficiency or concurrent measles infection.

Key words: vitamin A, pneumonia, children, Peru, respiratory, lung, retinol.
.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Seguin-Devaux, Y. Devaux, V. Latger-Cannard, S. Grosjean, C. Rochette-Egly, F. Zannad, C. Meistelman, P.-M. Mertes, and D. Longrois
Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo
Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E525 - E535.
[Abstract] [Full Text] [PDF]